Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, told the Personalized Medicine Coalition this week that real-world studies are needed for a convergence of comparative effectiveness research and personalized medicine. Also at the meeting, the coalition and the Lewin Group unveiled a report on aligning CE research with efforts in personalized medicine, including product labels, payment guidelines and utilization management.

Related Summaries